CONOLIDINE NO FURTHER A MYSTERY

These effects, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the concept of targeting ACKR3 as a singular way to modulate the opioid program, which could open new therapeutic avenues for opioid-associated disorders.Name your collection: Identify needs to be les